Fox Chase patients may be eligible to receive third COVID-19 vaccine dose – Read More

MENU

Namrata (Neena) Vijayvergia, MD

Namrata (Neena) Vijayvergia, MD

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111

About

Assistant Chief, Gastrointestinal Medical Oncology

Assistant Professor, Department of Hematology/Oncology

Medical Director, Medical Oncology, Fox Chase Cancer Center Partners

Research Program

Treatment Philosophy

Coming from a family of 12 doctors, I wanted to be one for as long as I can remember. After graduating from medical school in India, I pursued Internal Medicine training at Temple University Hospital in Philadelphia, where I also served as a chief medical resident. During that time I became interested in oncology and clinical research. I recently completed my fellowship in hematology/oncology at Temple/Fox Chase Cancer Center and have been fortunate enough to stay on as faculty. Early in my training, I realized that I wanted to dedicate my career to help discover new therapies for patients with gastrointestinal cancers, with a particular focus on pancreatic and neuroendocrine malignancies. We have made significant progress but a lot still needs to be done.

... Expand

Education and Training

Educational Background

  • Fellow, Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, 2012-2015
  • Resident, Temple University Hospital, Philadelphia, PA, 2008-2011
  • Bachelor of Medicine and Bachelor of Surgery (MBBS), Jawaharlal Nehru Medical College, University of Rajasthan, Ajmer, India, 2007

Certifications

  • American Board of Internal Medicine

Memberships

  • American Society of Clinical Oncology
  • American Society of Hematology
  • North American Neuroendocrine Tumor Society
  • American Medical Association
  • Indian Medical Association

Honors & Awards

  • Top Physicians Under 40 2020, Pennsylvania Medical Society
Patient Stories

Dennis Haring

Neuroendocrine Tumors

Dennis Haring

Neuroendocrine Tumors

I am in good hands with my care team. Their multidisciplinary approach made it possible for me to regain my quality of life and look forward to my future.

Melvin Ward

Neuroendocrine Tumors

Melvin Ward

Neuroendocrine Tumors

My care team at Fox Chase had such a confident and laid-back demeanor. We were on the same page, and their expertise made me feel more secure.

Ardelle Clarke

Neuroendocrine Tumors

Ardelle Clarke

Neuroendocrine Tumors

I plan on having a very, very long life. I’m 66 years old and I run a daycare in Havertown, Pennsylvania. Until I was diagnosed, I had no symptoms to speak of and had lived a healthy lifestyle. That’s why when doctors told me I had carcinoid tumors, I had trouble believing I was really sick.

Research Profile

Research Program

Research Interests

Neuroendocrine Tumors
Pancreatic Cancer
Outcomes Research
Publications

Selected Publications

Vijayvergia, N., Denlinger, C., Survivorship in Non-Small Cell Lung Cancer:Challenges Faced and Steps Forward. Manuscript submitted to JNCCN. 2015  PubMed

Vijayvergia, N., Dotan, E., Cohen, S.J., Predictors of long-term survival with metastatic pancreatic cancer (mPC) in the gemcitabine era: The Fox Chase Cancer Center experience. Manuscript submitted to Cancer. 2015  PubMed

Matthews, E., Zhou, L., Vijayvergia, N., El-Deiry, W., A Multiplexed Marker-based Algorithm for Diagnosis of Carcinoma of Unknown Primary Using Circulating Tumor Cells, Poster accepted for presentation at AACR 2015. 2014 

Vijayvergia, N., Cohen, S.J., Predictors of long-term survival with metastatic pancreatic cancer (mPC) in the gemcitabine era: The Fox Chase Cancer Center experience. J Clin Oncol 33, 2015 (suppl 3; abstr 253). 2014

Vijayvergia, N., Engstrom, P.F., Molecular profiling of advanced stage Neuro Endocrine Tumors (NETs): The Fox Chase Cancer Center (FCCC) experience. Poster presented at NANETS annual symposium 2014 and GI ASCO Symposium 2015 (JClin Oncol 33, 2015 (suppl 3; abstr 245)

Vijayvergia N, Mehra R. Clinical challenges in targeting anaplastic lymphoma kinase in advanced non-small cell lung cancer. Cancer Chemother Pharmacol. 2014 Sep;74(3):437-46

Ratings

118 PATIENT SATISFACTION REVIEWS

Our Patient Satisfaction Rating is an average of all responses to care provider related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more.

OVERALL RATING

4.7 / 5.0

RATINGS BREAKDOWN

  • 4.8
  • 4.7
  • 4.8
  • 4.8
  • 4.6

12 PATIENT COMMENTS

  • 5.0
    April 26, 2021
    I always have very positive experiences with physicians and staff during office visits. The physician, Dr, Vjvergia is helpful, informative and pleasant. She addressed my concerns fully and was very reassuring. The only challenge was in getting an appointment to see her. After I reached her contact on the phone, I was told someone would call me to set up an appointment but over a week went by and I called to check. Then a day after I was contacted with an appointment time.
  • 5.0
    March 30, 2021
    exceeds all expectations
  • 5.0
    March 25, 2021
    Dr. Vijayvergia is simply one of the best!
  • 5.0
    February 01, 2021
    Dr. Vijayvergia and her staff is very caring to my needs and very good.
  • 5.0
    December 02, 2020
    Dr. Vijayvergia was wonderful. [...]
  • 5.0
    November 02, 2020
    Always a good experience.
  • 5.0
    September 01, 2020
    Dr. Vijayvergia continues & provide expert and caring treatment for my neuroendocrine cancer.
  • 5.0
    July 27, 2020
    Dr. VJ is the best for me I love her.
  • 5.0
    July 22, 2020
    I always feel comfortable with Dr Vijay!
  • 5.0
    May 04, 2020
    Dr Vj team is great
  • 5.0
    April 20, 2020
    Good experience all around.
  • 5.0
    April 16, 2020
    Due to COVID-19 I didn't go to the office but spoke with the doctor on the phone. This was a new experience but I feel it went well.
LOAD MORE

Connect with Fox Chase